Taysha Gene Therapies, Inc. (TSHA)
4.39
-0.10
(-2.23%)
USD |
NASDAQ |
Oct 06, 16:00
4.45
+0.06
(+1.37%)
After-Hours: 20:00
Taysha Gene Therapies Price : 4.39 for Oct. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 4.51 | 4.57 | 4.26 | 4.39 | 4.836M |
| Oct 05, 2026 | 4.64 | 4.64 | 4.37 | 4.49 | 4.975M |
| Oct 02, 2026 | 4.80 | 4.86 | 4.63 | 4.63 | 2.990M |
| Oct 01, 2026 | 4.86 | 4.935 | 4.73 | 4.74 | 3.848M |
| Sep 30, 2026 | 5.03 | 5.03 | 4.82 | 4.87 | 3.902M |
| Sep 29, 2026 | 4.97 | 5.03 | 4.80 | 4.99 | 6.570M |
| Sep 28, 2026 | 4.64 | 5.055 | 4.56 | 4.99 | 6.262M |
| Sep 25, 2026 | 4.88 | 4.88 | 4.665 | 4.67 | 4.661M |
| Sep 24, 2026 | 4.88 | 4.90 | 4.655 | 4.79 | 6.405M |
| Sep 23, 2026 | 5.11 | 5.14 | 4.88 | 4.91 | 5.507M |
| Sep 22, 2026 | 5.11 | 5.215 | 5.082 | 5.16 | 2.306M |
| Sep 21, 2026 | 5.07 | 5.124 | 4.995 | 5.04 | 1.676M |
| Sep 18, 2026 | 5.16 | 5.28 | 4.96 | 5.02 | 9.117M |
| Sep 17, 2026 | 5.25 | 5.46 | 5.05 | 5.16 | 4.082M |
| Sep 16, 2026 | 5.08 | 5.135 | 4.975 | 5.07 | 4.347M |
| Sep 15, 2026 | 5.00 | 5.19 | 4.90 | 5.06 | 5.149M |
| Sep 14, 2026 | 5.00 | 5.12 | 4.98 | 5.01 | 6.696M |
| Sep 11, 2026 | 5.26 | 5.28 | 4.98 | 5.02 | 1.778M |
| Sep 10, 2026 | 5.24 | 5.24 | 5.01 | 5.16 | 2.403M |
| Sep 09, 2026 | 5.40 | 5.485 | 5.285 | 5.34 | 1.811M |
| Sep 08, 2026 | 5.57 | 5.575 | 5.40 | 5.48 | 2.223M |
| Sep 04, 2026 | 5.52 | 5.61 | 5.42 | 5.60 | 2.111M |
| Sep 03, 2026 | 5.62 | 5.665 | 5.50 | 5.57 | 1.878M |
| Sep 02, 2026 | 5.73 | 5.96 | 5.55 | 5.64 | 1.989M |
| Sep 01, 2026 | 5.645 | 5.77 | 5.56 | 5.70 | 1.763M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Altimmune, Inc. | 2.67 |
| Protalix Biotherapeutics, Inc. | 2.73 |
| Humacyte, Inc. | 0.478 |
| Agenus, Inc. | 7.49 |
| Amgen, Inc. | 402.60 |
Price Related Metrics
| PS Ratio | 274.93 |
| PEG Ratio | -0.4815 |
| Price to Book Value | 3.688 |
| Earnings Yield | -9.85% |
| Market Cap | 1.428B |
| PEGY Ratio | -0.4815 |